PT - JOURNAL ARTICLE AU - Rahbé, Eve AU - Glaser, Philippe AU - Opatowski, Lulla TI - Modeling the transmission of antibiotic-resistant Enterobacterales in the community: a systematic review AID - 10.1101/2024.01.15.24301323 DP - 2024 Jan 01 TA - medRxiv PG - 2024.01.15.24301323 4099 - http://medrxiv.org/content/early/2024/01/16/2024.01.15.24301323.short 4100 - http://medrxiv.org/content/early/2024/01/16/2024.01.15.24301323.full AB - Background Infections by antibiotic-resistant Enterobacterales are a public health threat worldwide. While dissemination of these opportunistic pathogens has been largely studied in hospitals, less is known about their acquisition and spread in the community. Here, we aim to characterize mechanistic hypotheses and scientific contributions of mathematical modeling studies focusing on antibiotic-resistant Enterobacterales in the community.Methods We conducted a systematic review of mathematical modeling studies indexed in PubMed and focusing on the transmission of antibiotic-resistant Enterobacterales in the community (i.e., excluding models only specific to hospitals). For each study, we extracted model features (host population, setting), formalism (compartmental, individual-based), biological hypotheses (transmission, infection, antibiotic use impact, resistant strain specificities) and main findings. We discussed additional mechanisms to be considered, open scientific questions, and most pressing data needs to further improve upon existing epidemiological modeling.Results We identified 18 modeling studies focusing on the human transmission of antibiotic-resistant Enterobacterales in the community (n=11) or in both community and hospital (n=7). Models aimed at: (i) understanding mechanisms driving resistance dynamics; (ii) identifying and quantifying transmission routes; or (iii) evaluating public health interventions to reduce resistance. Studies highlighted that community transmission, compared to hospital transmission, play a significant role in the overall acquisition of antibiotic-resistant Escherichia coli. Predictions across models regarding the success of public health interventions to reduce resistance rates depended on pathogens, settings, and antibiotic resistance mechanisms. For E. coli, lowered person-to-person transmission led to greater reduction in antibiotic resistance rates compared to lowered antibiotic use in the community (n=2). For Klebsiella pneumoniae lowered antibiotic use in the hospital led to greater reduction compared to lowered use in the community (n=2). Finally, we reported a moderate number of modeling studies inferring parameters from empirical data (n=9), probably due to a critical lack of available data for antibiotic resistance rates in the community.Conclusions We found a limited number of modeling studies addressing the transmission of antibiotic-resistant Enterobacterales in the community, highlighting a need for model development and extensive community-based data collection. Such modeling will be critical to better understand the spread of antibiotic-resistant Enterobacterales in the community and design public health interventions specific to this setting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementER work was funded by an independent research Pfizer Global Medical Grant (number 57504809). LO and PG work was funded by the French Government Investissement d Avenir program Laboratoire d Excellence Integrative Biology of Emerging Infectious Diseases (Grant ANR-10-LABX-62-IBEID).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.